BACE1 and Alzheimer disease: The model effectively meets the criteria for Alzheimer’s disease (AD) formation, demonstrated by significant memory impairment, increased levels of brain lipid peroxidation biomarkers, elevated inflammatory cytokines, BACE1, and the presence of Aβ deposits.